Circadian Epigenetic Ketone Synchronization Protocol

Target: CLOCK/BMAL1 Composite Score: 0.543 Price: $0.54 Citation Quality: Pending metabolic neuroscience Status: proposed Variant of Epigenetic Priming Ketone Protocol

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

C+

Composite: 0.543

Top 71% of 984 hypotheses

T2 Supported

Literature-backed with debate validation

Needs convergence ≥0.40 (current: 0.00) for Established

A Mech. Plausibility 15% 0.80 Top 24%

F Evidence Strength 15% 0.00 Top 50%

F Novelty 12% 0.00 Top 50%

F Feasibility 12% 0.00 Top 50%

F Impact 12% 0.00 Top 50%

A+ Druggability 10% 0.90 Top 17%

B Safety Profile 8% 0.60 Top 37%

A Competition 6% 0.80 Top 26%

B+ Data Availability 5% 0.70 Top 34%

B Reproducibility 5% 0.60 Top 48%

Evidence

3 supporting | 2 opposing

Citation quality: 0%

Debates

1 session A

Avg quality: 0.80

Convergence

0.00 F 7 related hypothesis share this target

From Analysis:

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and how much ketosis provides benefit vs harm. The 'metabolic steal syndrome' hypothesis suggests timing could be critical but remains untested. Source: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (7)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Epigenetic Priming Ketone Protocol

Score: 0.882 | Target: HDAC2/HDAC3

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | Target: HMGCS2

Astrocyte-Neuron Metabolic Coupling Titration

Score: 0.704 | Target: BDH1

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | Target: IRAKM

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | Target: OXCT1

Glucose-Ketone Metabolic Switch Timing

Score: 0.531 | Target: GLUT1/GLUT3/MCT1/MCT2

Age-Stratified Ketone Dosing Matrix

Score: 0.452 | Target: OXCT1

→ View full analysis & all 8 hypotheses

Description

Brief intermittent ketogenic exposures (2-4 hour pulses of 2-3 mM β-hydroxybutyrate) administered during specific circadian phases (late sleep/early wake transition, 2-3 times weekly) enhance neuroprotective gene expression through synchronized modulation of CLOCK/BMAL1 transcriptional complexes and chromatin remodeling. β-hydroxybutyrate acts as a circadian metabolite signal that directly influences the molecular clock machinery by promoting acetyl-CoA availability for histone acetylation at clock-controlled gene promoters, particularly those regulating neuronal stress response pathways including BDNF, PGC-1α, and antioxidant enzymes.

...

No AI visual card yet

3D Protein Structure

PDB: Open in RCSB AlphaFold model

Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 5 with PMID Validation: 0% 3 supporting / 2 opposing

✓ For (3)

No supporting evidence

No opposing evidence

(2) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 1CLIN 1GENE 3EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
Ketone bodies regulate epigenetic and post-transla…	Supporting	GENE	-	-	-	-	PMID:38203294	-
β-hydroxybutyrate has multifaceted influence on au…	Supporting	GENE	-	-	-	-	PMID:40583323	-
The compound promotes BDNF expression under adequa…	Supporting	MECH	-	-	-	-	PMID:29966721	-
Continuous exposure might be more effective for su…	Opposing	GENE	-	-	-	-	PMID:36297110	-
Clinicopathological features and prediction values…	Opposing	CLIN	Anticancer Drug…	-	2018	-	PMID:29481474	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 3

Ketone bodies regulate epigenetic and post-translational modifications of histones and non-histone proteins

PMID:38203294

β-hydroxybutyrate has multifaceted influence on autophagy, mitochondrial metabolism, and epigenetic regulation

PMID:40583323

The compound promotes BDNF expression under adequate glucose conditions

PMID:29966721

✗ Opposing Evidence 2

Continuous exposure might be more effective for sustained gene expression changes than intermittent protocol

PMID:36297110

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lym…▼

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.

Anticancer Drugs · 2018 · PMID:29481474

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-03 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Based on my research into ketone metabolism, neuroprotection, and the metabolic steal syndrome hypothesis, I'll generate novel therapeutic hypotheses for optimal timing and dosing of ketogenic interventions.

Novel Therapeutic Hypotheses for Ketogenic Neuroprotection

1. Circadian-Gated Ketone Window Hypothesis

Description: Ketone body utilization efficiency follows circadian rhythms, with optimal neuroprotective windows occurring during natural fasting periods (18:00-06:00). β-hydroxybutyrate administered during these periods maximizes mitochondrial efficiency while minimizing

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Based on my analysis of the available research, here is my critical evaluation of each hypothesis:

Critical Analysis of Ketogenic Neuroprotection Hypotheses

1. Circadian-Gated Ketone Window Hypothesis

Specific Weaknesses:

The PMID:17126577 citation is vague and doesn't specifically support circadian variations in OXCT1 expression or ketone utilization efficiency
No direct evidence provided for the claimed 18:00-06:00 optimal window
Assumption that circadian energy metabolism variations translate to ketone-specific therapeutic windows is unsubstantiated

**Counter-Eviden

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Druggability Assessment for Ketogenic Neuroprotection Hypotheses

Based on my analysis of the target proteins and therapeutic landscape, here's a comprehensive assessment of the practical feasibility for each surviving hypothesis:

1. Circadian-Gated Ketone Window Hypothesis (Target: OXCT1)

Revised Confidence: 0.35

Druggability Assessment

POOR DRUGGABILITY - OXCT1 is a mitochondrial matrix enzyme that catalyzes CoA transfer reactions. The active site is highly conserved and essential for cellular metabolism, making selective modulation extremely challenging without disrupting

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 0.0%

Volatility

Low

0.0000

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

Paper:29481474

No extracted figures yet

Beta-hydroxybutyrate Promotes the Expression of BDNF in Hippocampal Neurons under Adequate Glucose Supply.

Neuroscience (2019) · PMID:29966721

No extracted figures yet

Toxicity Investigations of (R)-3-Hydroxybutyrate Glycerides In Vitro and in Male and Female Rats.

Nutrients (2022) · PMID:36297110

No extracted figures yet

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases.

International journal of molecular sciences (2024) · PMID:38203294

No extracted figures yet

The Multifaceted Influence of Beta-Hydroxybutyrate on Autophagy, Mitochondrial Metabolism, and Epigenetic Regulation.

Journal of cellular biochemistry (2025) · PMID:40583323

No extracted figures yet

📓 Linked Notebooks (1)

📓 What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? - Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-03-gap-debate-20260403-222618-2709aad9. While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and ho …

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

Origin

mutate · gen 1

parent: h-d7212534

→ Browse all arenas & tournaments

KG Entities (14)

BDH1 GLUT1/GLUT3/MCT1/MCT2 HDAC2/HDAC3 HMGCS2 IRAKM OXCT1 h-17a2da3f h-404bab00 h-6df1bc66 h-9d4571a7 h-a1d97415 h-a947032c h-d7212534 metabolic_neuroscience

Related Hypotheses

Epigenetic Priming Ketone Protocol

Score: 0.882 | metabolic neuroscience

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | metabolic neuroscience

Astrocyte-Neuron Metabolic Coupling Titration

Score: 0.704 | metabolic neuroscience

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | metabolic neuroscience

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | metabolic neuroscience

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (13 edges)

associated with (6)

HDAC2/HDAC3 → metabolic_neuroscience

HMGCS2 → metabolic_neuroscience

BDH1 → metabolic_neuroscience

IRAKM → metabolic_neuroscience

OXCT1 → metabolic_neuroscience

...and 1 more

targets (7)

h-d7212534 → HDAC2/HDAC3

h-6df1bc66 → HMGCS2

h-17a2da3f → BDH1

h-a1d97415 → IRAKM

h-9d4571a7 → OXCT1

...and 2 more

Mechanism Pathway for CLOCK/BMAL1

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    h_d7212534["h-d7212534"] -->|targets| HDAC2_HDAC3["HDAC2/HDAC3"]
    h_6df1bc66["h-6df1bc66"] -->|targets| HMGCS2["HMGCS2"]
    h_17a2da3f["h-17a2da3f"] -->|targets| BDH1["BDH1"]
    h_a1d97415["h-a1d97415"] -->|targets| IRAKM["IRAKM"]
    h_9d4571a7["h-9d4571a7"] -->|targets| OXCT1["OXCT1"]
    h_a947032c["h-a947032c"] -->|targets| GLUT1_GLUT3_MCT1_MCT2["GLUT1/GLUT3/MCT1/MCT2"]
    h_404bab00["h-404bab00"] -->|targets| OXCT1_1["OXCT1"]
    HDAC2_HDAC3_2["HDAC2/HDAC3"] -->|associated with| metabolic_neuroscience["metabolic_neuroscience"]
    HMGCS2_3["HMGCS2"] -->|associated with| metabolic_neuroscience_4["metabolic_neuroscience"]
    BDH1_5["BDH1"] -->|associated with| metabolic_neuroscience_6["metabolic_neuroscience"]
    IRAKM_7["IRAKM"] -->|associated with| metabolic_neuroscience_8["metabolic_neuroscience"]
    OXCT1_9["OXCT1"] -->|associated with| metabolic_neuroscience_10["metabolic_neuroscience"]
    style h_d7212534 fill:#4fc3f7,stroke:#333,color:#000
    style HDAC2_HDAC3 fill:#ce93d8,stroke:#333,color:#000
    style h_6df1bc66 fill:#4fc3f7,stroke:#333,color:#000
    style HMGCS2 fill:#ce93d8,stroke:#333,color:#000
    style h_17a2da3f fill:#4fc3f7,stroke:#333,color:#000
    style BDH1 fill:#ce93d8,stroke:#333,color:#000
    style h_a1d97415 fill:#4fc3f7,stroke:#333,color:#000
    style IRAKM fill:#ce93d8,stroke:#333,color:#000
    style h_9d4571a7 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1 fill:#ce93d8,stroke:#333,color:#000
    style h_a947032c fill:#4fc3f7,stroke:#333,color:#000
    style GLUT1_GLUT3_MCT1_MCT2 fill:#ce93d8,stroke:#333,color:#000
    style h_404bab00 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1_1 fill:#ce93d8,stroke:#333,color:#000
    style HDAC2_HDAC3_2 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience fill:#ef5350,stroke:#333,color:#000
    style HMGCS2_3 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_4 fill:#ef5350,stroke:#333,color:#000
    style BDH1_5 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_6 fill:#ef5350,stroke:#333,color:#000
    style IRAKM_7 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_8 fill:#ef5350,stroke:#333,color:#000
    style OXCT1_9 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_10 fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 CLOCK — PDB 4F3L Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

metabolic neuroscience | 2026-04-03 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)